Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models

Doxorubicin (DOX) is an anthracycline widely used in cancer therapy and in particular in breast cancer treatment. The treatment with DOX appears successful, but it is limited by a severe cardiotoxicity. This work evaluated the in vitro and in vivo anticancer effect of a new formulation of β-cyclodex...

Descripción completa

Detalles Bibliográficos
Autores principales: Argenziano, Monica, Gigliotti, Casimiro Luca, Clemente, Nausicaa, Boggio, Elena, Ferrara, Benedetta, Trotta, Francesco, Pizzimenti, Stefania, Barrera, Giuseppina, Boldorini, Renzo, Bessone, Federica, Dianzani, Umberto, Cavalli, Roberta, Dianzani, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016577/
https://www.ncbi.nlm.nih.gov/pubmed/31936526
http://dx.doi.org/10.3390/cancers12010162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016577/
https://www.ncbi.nlm.nih.gov/pubmed/31936526
http://dx.doi.org/10.3390/cancers12010162

Ejemplares similares